Clinical trial Recruiting at 1 site Observational Ages 18 and up

Predictors of Breast Implant Rupture in Women with Aesthetic Silicone Implants

Official title: Prospective Longitudinal Cohort Study of Implant Age, Pocket Plane, Incision, Surface Texture, and Volume as Predictors of Breast Implant Rupture

Run by Research Inc · NCT07810205 · Data updated 2026-11-12

This study follows women with silicone breast implants over time to see which implant details and surgical choices are linked to rupture.

More Breast Implant Rupture trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment3000 (estimated)
SponsorResearch Inc
Industry-sponsored
Locations1 site (Medellín)
StatusRecruiting
StartedJanuary 12, 2014
Main results expectedJanuary 1, 2026
Study endsDecember 15, 2026
Registry record updatedSeptember 9, 2026
Trial IDNCT07810205 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women (18+) with permanent silicone aesthetic breast implants, with known implantation details and intact implants at baseline willing to five years of surveillance.

Probably not a fit

Patients with prior rupture, reconstructive implants, or planned explantation at enrollment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective cohort observes women with intact aesthetic silicone breast implants for up to five years, collecting data on implant age, pocket plane, incision route, surface texture, and volume. Annual high-resolution ultrasound screens for rupture, with MRI or surgery confirmation when rupture is suspected. Survival analysis will estimate rupture-free duration and how patient- and device-related factors relate to rupture risk, using baseline and time-updated variables. Eligibility requires confirmed intact implants at enrollment and commitment to five years of follow-up.

Why it matters

Potential benefit: If successful, the study could clarify which implant characteristics are associated with rupture risk, informing patient choices and surveillance strategies.

How similar studies have gone: Previous observational work in implant surveillance has provided actionable risk insights, but this study adds prospective longitudinal data and specific device characteristics.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female sex and age 18 years or older.
* Aesthetic breast augmentation with permanent silicone implants.
* Known implantation date or sufficiently precise implantation year, pocket plane, incision route, surface texture, and implant volume.
* Both implants or the analyzed implant documented as intact at baseline by the study imaging algorithm.
* Ability to complete annual surveillance for up to five years.
* Written informed consent.

Exclusion Criteria:

* Reconstructive implantation after mastectomy, congenital deformity, or major trauma.
* Tissue expander or nonpermanent device.
* Confirmed rupture at cohort entry for the implant under analysis.
* PIP implant or another recalled device if the final protocol elects to exclude it from etiologic modeling.
* Missing core implant characteristics or implantation date.
* Planned immediate explantation or exchange at enrollment for a reason unrelated to surveillance.

Where it's running

  • IQ interquirofanos
    Medellín, Colombia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Follow-up on Euromi silicone gel breast implants

    This study is tracking patients with Euromi silicone gel breast implants for 10 years to see how safe and effective they are and to check for any problems like implant rupture.

    Recruiting Euromi Biosciences · Nancy · NCT05987475

  • Implant-based breast reconstruction after bariatric (weight-loss) surgery

    This registry-based project will use national data to see how common breast implants are and whether women who've had bariatric weight-loss surgery have different complication rates after implant-based breast augmentation or reconstruction.

    Recruiting Vastra Gotaland Region · Gothenburg · NCT07059104

  • Long-term follow-up of Motiva silicone breast implants

    This project sees if Motiva silicone breast implants are safe and work well over up to 10 years for adult women having primary or revision breast augmentation.

    Recruiting at 33 sites Motiva USA LLC · Beverly Hills, California and 32 other locations · NCT06938399

  • Identifying risk factors for seroma formation after breast surgery

    This study is trying to find out which patients are more likely to develop fluid buildup after breast surgery so that doctors can give better advice and care to prevent it.

    Recruiting University Hospital Augsburg · Augsburg, Bavaria · NCT05899387

  • Investigating bacterial biofilms in breast implant complications

    This study is trying to see if bacteria that form biofilms are linked to problems some people have with breast implants, especially those experiencing Breast Implant Illness.

    Recruiting at 3 sites Indiana University · Carmel, Indiana and 2 other locations · NCT05736354

  • Analysis of outcomes for women with Silimed® smooth surface breast implants

    This study is testing how safe and effective Silimed® smooth surface breast implants are for women getting breast augmentation, while also looking at their satisfaction and quality of life over 10 years.

    Recruiting Silimed Industria de Implantes Ltda · Santo André, São Paulo · NCT05345821

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.